Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time : a test-negative case-control study
Citation
Florentino , P T V , Millington , T , Cerqueira-Silva , T , Robertson , C , de Araújo Oliveira , V , Júnior , J B S , Alves , F J O , Penna , G O , Vital Katikireddi , S , Boaventura , V S , Werneck , G L , Pearce , N , McCowan , C , Sullivan , C , Agrawal , U , Grange , Z , Ritchie , L D , Simpson , C R , Sheikh , A , Barreto , M L , Rudan , I , Barral-Netto , M & Paixão , E S 2022 , ' Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time : a test-negative case-control study ' , The Lancet Infectious Diseases , vol. 22 , no. 11 , pp. 1577-1586 . https://doi.org/10.1016/S1473-3099(22)00451-0
Rights
Licensed under a Creative Commons CC-BY 4.0 license, article is free to read, share, and reuse, with attribution to the authors https://creativecommons.org/licenses/by/4.0/